课题基金 / 基金详情

Cocaine Addiction and Retrotransposons

Cocaine Addiction and Retrotransposons
可卡因成瘾和逆转录转座子
批准号:
8623126
负责人:
Wade H Berrettini
金额:
$19.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-01 至 2016-03-31

项目摘要

项目成果

Wade H Berrettini的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cocaine addiction (CA) is a common brain disorder, affecting ~ 1,000,000 adults in the US population, creating a significant public health problem because of its chronic nature and the associated morbidity and mortality. Although twin studies are consistent with an inherited component, it has been difficult to identify risk-increasing allels by studying DNA from blood or saliva. Retrotransposons (RTPs) are mobile DNA elements that are common in the human genome. In the past 5 years, data have accumulated to prove that neuronal embryogenesis is accompanied by activation of LINE1 (L1) RTPs to an unexpected degree, such that each developing neuron may accumulate multiple de novo L1 RTP genomic insertions, perhaps as many as ~80. This results in a substantial mosaicism within populations of CNS neurons. While most of these somatic de novo L1 RTP insertions will have little effect on neuronal function (perhaps because they occur in gene deserts or in large introns or in genes not required for that cell's function), some may interfere with normal neuronal activity because they have inserted into a gene needed by that particular neuron for normal function. If one or more functional L1 RTP insertion events occur early in CNS development, all the daughter neurons that derive from that neuronal precursor will also carry the L1 insertion, perhaps leading to a dysfunctional population of neurons destined to convey risk for CA. This application will leverage post-mortem brain tissue from CA patients, who have died from a cocaine overdose, and age/gender/ethnicity matched post-mortem brain tissue from controls. Laser capture microdissection will be used to harvest distinct populations of medial frontal cortex, amygdala and striatum (brain regions implicated in neuroadaptation in CA animal models). DNA from these neurons will be analyzed by high-throughput sequencing, to detect de novo L1 RTP insertions. Any de novo (not in the reference genome) L1 RTP insertion detected in a brain-expressed gene will be investigated for functional significance using standard assays of transcription. In this manner, it is expected that novel de novo somatic L1 RTP insertions, that increase risk for CA, will be discovered.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical and Genetic Study of Prescription Opioid Addiction
  • 批准号:
    9405766
  • 项目类别:
  • 资助金额:
    $84.52万
  • 财政年份:
    2017
  • 负责人:
    Wade H Berrettini
  • 依托单位:
Clinical and Genetic Study of Prescription Opioid Addiction
  • 批准号:
    10180929
  • 项目类别:
  • 资助金额:
    $73.73万
  • 财政年份:
    2017
  • 负责人:
    Wade H Berrettini
  • 依托单位:
Retrotransposons in Schizophrenia
  • 批准号:
    9886270
  • 项目类别:
  • 资助金额:
    $51.87万
  • 财政年份:
    2016
  • 负责人:
    Wade H Berrettini
  • 依托单位:
Mobile DNA in Drug Abuse
  • 批准号:
    9128371
  • 项目类别:
  • 资助金额:
    $46.34万
  • 财政年份:
    2016
  • 负责人:
    Wade H Berrettini
  • 依托单位:
海外基金